Package 16714-194-01

Brand: lamotrigine

Generic: lamotrigine
NDC Package

Package Facts

Identity

Package NDC 16714-194-01
Digits Only 1671419401
Product NDC 16714-194
Description

100 TABLET in 1 BOTTLE (16714-194-01)

Marketing

Marketing Status
Marketed Since 2021-11-17
Brand lamotrigine
Generic lamotrigine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "f6d6f71c-c94d-4bde-ac57-850998dad74f", "openfda": {"nui": ["N0000175753", "N0000008486", "N0000175751", "N0000187061", "N0000000191"], "unii": ["U3H27498KS"], "rxcui": ["198427", "198428", "198429", "282401"], "spl_set_id": ["aabc64fe-1f17-4140-81f2-7d4506db6c8b"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]", "Mood Stabilizer [EPC]"], "pharm_class_moa": ["Organic Cation Transporter 2 Inhibitors [MoA]", "Dihydrofolate Reductase Inhibitors [MoA]"], "manufacturer_name": ["Northstar Rx LLC."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (16714-194-01)", "package_ndc": "16714-194-01", "marketing_start_date": "20211117"}], "brand_name": "Lamotrigine", "product_id": "16714-194_f6d6f71c-c94d-4bde-ac57-850998dad74f", "dosage_form": "TABLET", "pharm_class": ["Anti-epileptic Agent [EPC]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "Dihydrofolate Reductase Inhibitors [MoA]", "Mood Stabilizer [EPC]", "Organic Cation Transporter 2 Inhibitors [MoA]"], "product_ndc": "16714-194", "generic_name": "Lamotrigine", "labeler_name": "Northstar Rx LLC.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Lamotrigine", "active_ingredients": [{"name": "LAMOTRIGINE", "strength": "25 mg/1"}], "application_number": "ANDA077633", "marketing_category": "ANDA", "marketing_start_date": "20211117", "listing_expiration_date": "20271231"}